Trading Summary - November 4. A much better day for

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
109
Trading Summary - November 4.

A much better day for $EVSV today with a number of the top traders who have been watching it for some time sending a clear message to the iHub scammers by putting in bids in depth in the .2000 > .2500 range and hitting the fake undercut ask which kept moving around between .2800 / .2900 / .3000 / .3200.

All trades and manipulation attempts were reported contemporaneously in earlier posts.

In addition to the main nonsense posters on iHub who are the prime suspects in the manipulation - "searay2701" and "Bionic Man" - a new troll account "r32121", which was created in Oct 2019 specifically to bash $EVSV, reappeared. He has been added to the list of suspects for a potential report to the SEC - although the report will not be necessary provided we see above $1 as expected. At present, I'm not going to post on iHub correcting the incorrect basher narrative on trading as they don't appear to have recognized the building interest on the bid - so I'll let them leave their undercut asks up below .4000 for those currently bidding to grab over the next day or so.

The difference between buying anywhere between .2500 and .3500 is irrelevant when the pps is going to $1+.

Overall, another 13,355 shares were bought today - all in the "as near to .4000 as makes no difference" range which extends down to .2000 and up to .6000 in pre-r/s terms - all except an early 125 share paint down at .2200 - before the bids in depth came in - being at .2700 > .3000.

The Share Structure was updated on November 1, 2019 - showing no change from the previous update on October 30, 2019.

The latest DD / Rolling Brief is here:

https://investorshangout.com/post/view?id=5581852

The following items below the line unchanged since the last Trading Summary:

The 2019 Q2 was filed on August 7, 2019 in a timely manner and gave a very good description of the holding company $EVSV's current portfolio and partnerships (unable to copy - read in filing).

The top traders in $EVSV aren't going to waste out time nickel and diming trying to fill on the bid when there is so much else going on with Watch List stocks to attend to daily. We will just take out everything on the ask under 1.000 at a time of our choosing.

Top traders who are the movers and shakers of $EVSV will continue the transfer of more of their profits from other trades into $EVSV up until the first hemp crop revenues come out.

The usual moving around of the insignificant undercut asks below .4000 by the iHub scammers of course has no effect and they are currently being allowed to continue to post to themselves on iHub completely oblivious to the fact that all traders of significance are networking by other means.

Their modus operandi hasn't changed for over 10 months since they failed to buy at .0001 on the day before the successful r/s: post blatant nonsense on iHub + attempt to support their fake narrative by trading at or below the visible bid price (often with orders placed before the open + then not pay attention to actual other trading that follows + attempt to walk a small ask down to artificially low levels + not realize that their manipulation attempts don't affect the views of the 129 social media OTC influencers who have $EVSV on their radar now.

All these manipulation attempts enable top traders on low commission rates - who don't have to worry about partial fills - to just keep accumulating cheap shares almost daily.

As I have warned before, the scammers who attempt paint downs on thin stocks are likely to find themselves detected by their brokers compliance department and reported to the SEC. This is what will then happen:

https://www.sec.gov/news/press-release/2019-216

I'll be continuing to implement #boycottiHub but I have now alerted both Penny Stock Geeks and a couple of top trader rooms in Skype that there may be a dramatic move at any time.

In addition of course we have 129 traders / analysts / alerters on social media that have $EVSV on their radar to start scaling in and / or jumping on board "just-in-time".






Enviro-Serv, Inc. (EVSV) Stock Research Links

EVSV Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Cytokinetics Faces Class Action: What You Need to Know

Updated Category News Views 175

Understanding the Class Action Lawsuit Against Cytokinetics Cytokinetics, Incorporated is currently facing a significant class action lawsuit initiated by shareholders. This legal challenge brings to light serious allegations against the Company regarding their disclosures and expectations for FDA approval of a key drug. Details of the Allegations The lawsuit asserts that...

Continue Reading
Discover the Embodied Luxury of the Champagne Specialist Course

Updated Category News Views 207

Verona Hosts the Esteemed Champagne Specialist Course The Italian Wine Academy is excited to announce a remarkable opportunity for wine enthusiasts and professionals. In Verona, for the very first time, the Academy will conduct the prestigious Comité Champagne 'Champagne Specialist' course. This unique program will be available in both English and Italian, providing an...

Continue Reading
MiniLuxe Achieves Strong Q1 2025 Growth with Strategic Focus

Updated Category News Views 378

MiniLuxe Reports Strong Financial Performance for Q1 2025 Reported figures all in U.S. Dollars MiniLuxe Holding Corp. (TSXV: MNLX) has announced exciting financial results for its first quarter of the year. This period showcased a significant 9% growth in revenue, reaching an impressive $6.1 million. Coupled with a gross profit of $2.5 million, reflective of a 12%...

Continue Reading
Transforming Shopify: AI Product Discovery for Enterprises

Updated Category News Views 141

Fredhopper's New App for Shopify Fredhopper Introduces Cutting-Edge Product Discovery Solutions The ecommerce landscape is evolving rapidly, and innovation is at the forefront. Fredhopper has launched its Product Discovery App for Shopify, bringing advanced AI-powered product search and personalized recommendations directly into the hands of enterprise merchants. This...

Continue Reading
Quantum Computing Inc. Faces Class Action Lawsuit for Shareholders

Updated Category News Views 162

Understanding the Recent Class Action Against Quantum Computing Inc. In a significant turn of events, Quantum Computing Inc. has come under legal pressure as a class action lawsuit has been filed on behalf of its shareholders. The lawsuit comes in response to allegations of misleading information that may have adversely affected investors' financial interests. Class...

Continue Reading